With 0.51 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.26 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $4.6600 whereas the lowest price it dropped to was $4.3302. The 52-week range on AUGX shows that it touched its highest point at $5.97 and its lowest point at $1.01 during that stretch. It currently has a 1-year price target of $7.67. Beta for the stock currently stands at 0.22.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AUGX was down-trending over the past week, with a drop of -15.44%, but this was down by -16.54% over a month. Three-month performance dropped to -8.74% while six-month performance rose 10.86%. The stock gained 230.15% in the past year, while it has gained 187.82% so far this year. A look at the trailing 12-month EPS for AUGX yields -0.50 with Next year EPS estimates of -0.33. For the next quarter, that number is -0.11. This implies an EPS growth rate of 29.60% for this year and 28.99% for next year.
Float and Shares Shorts:
At present, 37.44 million AUGX shares are outstanding with a float of 31.83 million shares on hand for trading. On Oct 30, 2023, short shares totaled 0.73 million, which was 1.80% higher than short shares on Sep 28, 2023. In addition to Mr. Emmanuel Krakaris as the firm’s President, CEO, Secretary & Director, Mr. Ian Shakil serves as its Founder, Chief Strategy Officer & Director.
Institutional Ownership:
Through their ownership of 73.72% of AUGX’s outstanding shares, institutional investors have majority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AUGX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With AUGX analysts setting a high price target of $8.00 and a low target of $7.00, the average target price over the next 12 months is $7.67. Based on these targets, AUGX could surge 78.17% to reach the target high and rise by 55.9% to reach the target low. Reaching the average price target will result in a growth of 70.82% from current levels.
Summary of Insider Activity:
Insiders traded AUGX stock several times over the past three months with 2 Buys and 0 Sells. In these transactions, 4,184 shares were bought while 0 shares were sold. The number of buy transactions has increased to 13 while that of sell transactions has risen to 3 over the past year. The total number of shares bought during that period was 9,034,868 while 14,856,146 shares were sold.
